Supriya Lifescience shares hit 52-week high for 3rd straight session post strong listing; stocks surge over 80% on issue price

The shares of Supriya Lifescience surged over 13 per cent to new 52-week high of Rs 527.55 per share on the BSE in Thursday's intraday trade. The shares of active pharmaceutical ingredients supplier traded on new 52-week high value for the third straight session on Thursday after making a strong stock market debut on Tuesday. This was nearly 85 per cent jump in the sahre price Supriya Lifescience on its issue price. 

The shares after touching 52-week low of Rs 383.15 on its listing day have been continuously surging, creating new highs daily. The shares traded on new high of Rs 425 on October 28, followed by 468.40 on October 29.

See Zee Business Live TV Streaming Below:

At 2.45 pm, shares of this active pharmaceutical ingredients' supplier were trading at Rs 517.00, a gain of Rs 53.95 or 11.65% on the BSE.  

The shares of Supriya Lifescience were listed at Rs 425, a gain of Rs 151 apiece, against its issue price of Rs 274 on the BSE on Tuesday. The shares opened at Rs 421, a gain of Rs 147 or 53.65%, on the NSE on Tuesday. The listing was in line with the street's expectations as a majority of analysts have predicted similar outcomes for Supriya Lifescience debut.  

Incorporated in March 2008, the company had a niche product portfolio of 38 APIs, with focus primarily on diverse therapeutic areas, and it had also been consistently India’s largest exporter of certain niche products with well-balanced presence between regulated and semi/non-regulated markets.

From April 1, 2020, until October 31, 2021, the company's products were exported to 86 countries to 1,296 customers including 346 distributors.